Answers are grounded in this paper and cite their sources.
Abstract The pace of biological aging varies between people independently of chronological age and mitochondria dysfunction is a key hallmark of biological aging. We hypothesized that higher functional impact (FI) score of mitochondrial DNA (mtDNA) variants might contribute to premature aging and tested the relationships between a novel FI score of mtDNA variants and epigenetic and biological aging in young adulthood. A total of 81 participants from the European Longitudinal Study of Pregnancy and Childhood (ELSPAC) prenatal birth cohort had good quality genetic data as well as blood-based markers to estimate biological aging in the late 20. A subset of these participants (n = 69) also had epigenetic data to estimate epigenetic aging in the early 20s using Horvath’s epigenetic clock. The novel FI score was calculated based on 7 potentially pathogenic mtDNA variants. Greater FI score of mtDNA variants was associated with older epigenetic age in the early 20s (AdjR²=0.19, beta = 0.29, p = 0.009) and older biological age in the late 20s (AdjR²=0.23, beta = 0.24, p = 0.018). These effects were independent of sex, current BMI, and cigarette smoking. These findings suggest that elevated FI score of mtDNA variants might contribute to premature aging in young adulthood.
No takes yet. Share an insight, caveat, or question.
Marečková et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: